RFK Jr. in Power, NIH and FDA on the Chopping Block, & Interest Rates Loom Large

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more.